General Analysis of Adicet Bio, Inc. Dated: 25th July 2024

This general information may attract short-term investors. - Current Price: The current price of Adicet Bio Inc. stock is $1.45 per share - Price Change: The stock price has changed by $0.01 or 0.6944% from the previous day's closing price - 52-Week Range: The stock price has fluctuated between a high of $3.77 and a low of $1.05 over the past 52 weeks - Analyst Rating: The average analyst rating for Adicet Bio Inc. stock is "Strong Buy - Price Target: The average 12-month price target for Adicet Bio Inc. stock is $14.20, representing a potential increase of 879.31% from the current price - Financial Performance: Adicet Bio Inc. is a clinical-stage biotechnology company with no commercial products yet, and its financial performance is focused on research and development expenses - Product Pipeline: The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy in Phase I clinical trial for autoimmune diseases and non-Hodgkin's lymphoma - Industry: Adicet Bio Inc. operates in the biotechnology industry, specifically in the field of gamma delta T cell therapies for autoimmune diseases and cancer. Disclaimer: Please note, it’s a general post and not intended for any personal advice The information provided by Buttonwood Edge is general information or an overview. It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. The company accepts no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon.

General Analysis of Adicet Bio, Inc. Dated: 25th July 2024

General Analysis of Adicet Bio, Inc. Dated: 25th July 2024

RECENT POST